<- Go Home
Cochlear Limited
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.
Market Cap
AUD 12.0B
Volume
161.8K
Cash and Equivalents
AUD 187.1M
EBITDA
AUD 562.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
AUD 1.7B
Profit Margin
72.76%
52 Week High
AUD 319.56
52 Week Low
AUD 169.03
Dividend
2.34%
Price / Book Value
6.19
Price / Earnings
34.82
Price / Tangible Book Value
8.37
Enterprise Value
AUD 12.0B
Enterprise Value / EBITDA
20.18
Operating Income
AUD 503.4M
Return on Equity
18.15%
Return on Assets
11.28
Cash and Short Term Investments
AUD 187.1M
Debt
AUD 242.2M
Equity
AUD 1.9B
Revenue
AUD 2.3B
Unlevered FCF
AUD 111.3M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium